Travere Therapeutics, Inc. TVTX EV / EBITDA
EV / EBITDA at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s ev / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s EV / EBITDA?
- Travere Therapeutics, Inc. (TVTX) reported EV / EBITDA of 166.4× in Q1 2026.
- What does EV / EBITDA mean?
- Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.